Search results
Results from the WOW.Com Content Network
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The intent of the program is to allow covered entities to "stretch scarce federal resources as far as possible ...
340B Drug Program is applicable to hospitals (mixed-use and outpatient clinics) and contract pharmacies. The 340B Program is often managed by software for maximizing the savings and for providing compliance. 340BSoftware.com is an example of such software. The Program is a federal program.
One of the following programs is the 340B pricing program that allows hospitals and pharmacists to buy drugs at 30–50% off the retail prices. [71] Per HRSA's 340B Drug Pricing Program, drug manufacturers are required to give certain organizations discounted drugs given these organizations fit the eligibility criteria for discounts. [72]
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law requiring pharmaceutical companies to negotiate drug prices with the ...
The 340B Drug Pricing Program is a federal program that allows certain hospitals to purchase outpatient drugs at discounted prices. 340B hospitals typically serve low-income or rural communities. The program allows the hospitals to reallocate scarce resources to provide more comprehensive services.
HRSA rejected Lilly's cash replenishment model for reimbursing entities covered by the 340B Drug Pricing Program. This federal program provides prescription medications at lower costs to eligible ...
Pharmaceutical companies are legally required to pay for a portion of the medications used by critical access hospitals as part of the 340B Drug Pricing Program. Few CAHs provide intensive care treatment. A review of CAHs in the early 2000s counted 26% of the hospitals providing intensive care-level treatment to at least one patient.
The 340B Drug Pricing Program is a U.S. federal program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations and covered entities at significantly reduced prices.